PMID- 23281061 OWN - NLM STAT- MEDLINE DCOM- 20130521 LR - 20131121 IS - 1531-8249 (Electronic) IS - 0364-5134 (Linking) VI - 73 IP - 2 DP - 2013 Feb TI - Matrix metalloproteinase 3 deletion preserves denervated motor endplates after traumatic nerve injury. PG - 210-23 LID - 10.1002/ana.23781 [doi] AB - OBJECTIVE: Traumatic peripheral nerve injuries often produce permanent functional deficits despite optimal surgical and medical management. One reason for the impaired target organ reinnervation is degradation of motor endplates during prolonged denervation. Here we investigate the effect of preserving agrin on the stability of denervated endplates. Because matrix metalloproteinase 3 (MMP3) is known to degrade agrin, we examined the changes in endplate structure following traumatic nerve injury in MMP3 knockout mice. METHODS: After creation of a critical size nerve defect to preclude reinnervation, we characterized receptor area, receptor density, and endplate morphology in denervated plantaris muscles in wild-type and MMP3 null mice. The level of agrin and muscle-specific kinase (MuSK) was assessed at denervated endplates. In addition, denervated muscles were subjected to ex vivo stimulation with acetylcholine. Finally, reinnervation potential was compared after long-term denervation. RESULTS: In wild-type mice, the endplates demonstrated time-dependent decreases in area and receptor density and conversion to an immature receptor phenotype. In striking contrast, all denervation-induced changes were attenuated in MMP3 null mice, with endplates retaining their differentiated form. Agrin and MuSK were preserved in endplates from denervated MMP3 null animals. Furthermore, denervated muscles from MMP3 null mice demonstrated greater endplate efficacy and reinnervation. INTERPRETATION: These results demonstrate a critical role for MMP3 in motor endplate remodeling, and reveal a potential target for therapeutic intervention to prevent motor endplate degradation following nerve injury. CI - Copyright (c) 2012 American Neurological Association. FAU - Chao, Tom AU - Chao T AD - Department of Orthopaedic Surgery, University of California, Irvine, Irvine, CA, USA. FAU - Frump, Derek AU - Frump D FAU - Lin, Michael AU - Lin M FAU - Caiozzo, Vincent J AU - Caiozzo VJ FAU - Mozaffar, Tahseen AU - Mozaffar T FAU - Steward, Oswald AU - Steward O FAU - Gupta, Ranjan AU - Gupta R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121231 PL - United States TA - Ann Neurol JT - Annals of neurology JID - 7707449 RN - 0 (Agrin) RN - 0 (Cholinergic Agonists) RN - 0 (Receptors, Cholinergic) RN - EC 2.7.10.1 (MuSK protein, mouse) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - EC 3.4.24.17 (Mmp3 protein, mouse) RN - N9YNS0M02X (Acetylcholine) SB - IM MH - Acetylcholine/pharmacology MH - Agrin/metabolism MH - Animals MH - Cell Line MH - Cholinergic Agonists/pharmacology MH - Disease Models, Animal MH - Gene Deletion MH - Male MH - Matrix Metalloproteinase 3/*genetics/*metabolism MH - Mice MH - Mice, 129 Strain MH - Mice, Knockout MH - Motor Activity/physiology MH - Motor Endplate/drug effects/*enzymology MH - Muscle Denervation/methods MH - Muscle, Skeletal/drug effects/innervation/pathology MH - Muscular Atrophy/metabolism/physiopathology MH - Nerve Regeneration/*physiology MH - Peripheral Nerve Injuries/*metabolism/*physiopathology MH - Receptor Protein-Tyrosine Kinases/metabolism MH - Receptors, Cholinergic/metabolism MH - Wallerian Degeneration/metabolism/physiopathology EDAT- 2013/01/03 06:00 MHDA- 2013/05/23 06:00 CRDT- 2013/01/03 06:00 PHST- 2012/06/12 00:00 [received] PHST- 2012/08/29 00:00 [revised] PHST- 2012/09/24 00:00 [accepted] PHST- 2013/01/03 06:00 [entrez] PHST- 2013/01/03 06:00 [pubmed] PHST- 2013/05/23 06:00 [medline] AID - 10.1002/ana.23781 [doi] PST - ppublish SO - Ann Neurol. 2013 Feb;73(2):210-23. doi: 10.1002/ana.23781. Epub 2012 Dec 31.